Averna Therapeutics
Averna Therapeutics is a life sciences company in Watertown, United States, founded in 2022. It has raised $82.0M across 1 round, most recently an $82.0M Series A in June 2024.
Delivering what's next in genetic medicine.
- Headquarters
- Watertown, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- avernatx.com
- Total Funding
- $82.0M
- Last Round
- $82.0M Series AJun 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
Averna Therapeutics (formerly Exsilio Therapeutics) is a biotechnology company developing RNA/lipid nanoparticle (LNP)-based genomic medicines designed to durably insert any gene or genetic instruction of interest into cells. The company's platform leverages site-specific retrotransposons — nature's precision gene insertion system — to safely integrate large sets of genetic instructions at safe harbor genomic locations without disrupting cell function. Averna's all-RNA system, delivered by LNPs, aims to expand the reach of genetic medicines beyond what viral approaches can achieve, broadening addressable diseases and patient populations. The company was recognized as a 2025 Endpoints 11 Most Promising Biotech.
Summary
It lists 11–50 employees. It has raised $82.0M in total across 1 round, most recently a $82.0M Series A round in Jun 2024. Investors include Novartis Venture Fund, Delos Capital and OrbiMed.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2024
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/averna-therapeutics"><img src="https://indexed.vc/api/badge/company/averna-therapeutics" alt="Averna Therapeutics on Indexed.vc" width="260" height="76" /></a>